We are live on ! Find out more
RACB

Research Alliance Corp. II Class A Common Stock
RACB

Delisted

RACB was delisted on the 1st of December, 2022.

Back to rankings

39 hedge funds and large institutions have $139M invested in Research Alliance Corp. II Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

0% more capital invested

Capital invested by funds: $139M → $139M (+$80.3K)

0% more funds holding

Funds holding: 39 → 39 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

Holders
39
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$18.7M
2
SCM
Shaolin Capital Management
Florida
+$5.87M
3
SC
Sculptor Capital
New York
+$3.81M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.28M
5
MTCM
Mint Tower Capital Management
Netherlands
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$12.9M
2
PA
Perceptive Advisors
New York
-$9.76M
3
FCMV
Foresite Capital Management V
California
-$4.88M
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$4.2M
5
BCM
Beryl Capital Management
California
-$3.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$1.03M +$1.03M +105,005 New
GCL
27
Glazer Capital LLC
New York
$926K -$78.3K -8,000 -8%
KIM
28
Karpus Investment Management
New York
$641K – – –
Barclays
29
Barclays
United Kingdom
$490K +$489K +50,000 New
CH
30
CVI Holdings
Delaware
$468K – – –
CSS
31
Cubist Systematic Strategies
Connecticut
$448K +$448K +45,765 New
SSA
32
Schonfeld Strategic Advisors
New York
$432K +$204K +20,830 +89%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$400K +$400K +40,873 New
JGC
34
J. Goldman & Co
New York
$391K – – –
EC
35
Elequin Capital
New York
$245K +$245K +25,000 New
DAM
36
Deltec Asset Management
New York
$244K – – –
DWM
37
Dakota Wealth Management
Florida
$152K – – –
Citigroup
38
Citigroup
New York
$15K +$14.7K +1,500 New
MF
39
Magnetar Financial
Illinois
$250 +$105K +10,763 +73%
HM
40
HealthCor Management
New York
– -$12.9M -1,324,800 Closed
PA
41
Perceptive Advisors
New York
– -$9.76M -1,000,000 Closed
FCMV
42
Foresite Capital Management V
California
– -$4.88M -500,000 Closed
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
– -$4.2M -430,052 Closed
BCM
44
Beryl Capital Management
California
– -$3.07M -315,000 Closed
CCM
45
Context Capital Management
California
– -$1.56M -159,987 Closed
Bank of America
46
Bank of America
North Carolina
– -$976K -100,000 Closed
DCM
47
DG Capital Management
New York
– -$178K -18,238 Closed
WAM
48
Wolverine Asset Management
Illinois
– -$11K -1,173 Closed
1
2

RACB Hedge Fund Activity: Q2 2022 in Review

39 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Research Alliance Corp. II Class A Common Stock (RACB) for Q2 2022, worth a combined $139M — up 0.06% from $139M a quarter earlier.

Fund positioning in RACB was balanced in Q2 2022: 9 funds opened new positions, 9 closed out, 7 added to existing stakes and 3 trimmed.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $18.7M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.9M sold.

  • 39 institutional investors held Research Alliance Corp. II Class A Common Stock (RACB) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $139M of Research Alliance Corp. II Class A Common Stock stock for Q2 2022, up 0.06% quarter-over-quarter.
  • 9 funds opened new Research Alliance Corp. II Class A Common Stock positions in Q2 2022 and 9 closed out, a net change of 0 holders.
  • The largest Research Alliance Corp. II Class A Common Stock buyer in Q2 2022 was Saba Capital Management, an estimated $18.7M added.
  • The largest Research Alliance Corp. II Class A Common Stock seller in Q2 2022 was HealthCor Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2022.